1-(2,6-Xylyl)-2-thiourea |
An analytical reference standard categorized as an anesthetic metabolite;… |
10 mg |
39373-10 |
More Info
|
1-(2,6-Xylyl)-2-thiourea |
An analytical reference standard categorized as an anesthetic metabolite;… |
50 mg |
39373-50 |
More Info
|
Y11 |
Inhibits FAK1 autophosphorylation by blocking phosphorylation of Y397; dec… |
1 mg |
18521-1 |
More Info
|
Y11 |
Inhibits FAK1 autophosphorylation by blocking phosphorylation of Y397; dec… |
10 mg |
18521-10 |
More Info
|
Y11 |
Inhibits FAK1 autophosphorylation by blocking phosphorylation of Y397; dec… |
25 mg |
18521-25 |
More Info
|
Y11 |
Inhibits FAK1 autophosphorylation by blocking phosphorylation of Y397; dec… |
5 mg |
18521-5 |
More Info
|
Y-26763 |
An activator of KATP channels; increases the frequency of KATP channel ope… |
1 mg |
21459-1 |
More Info
|
Y-26763 |
An activator of KATP channels; increases the frequency of KATP channel ope… |
10 mg |
21459-10 |
More Info
|
Y-26763 |
An activator of KATP channels; increases the frequency of KATP channel ope… |
5 mg |
21459-5 |
More Info
|
Y320 |
An inhibitor of the release of IL-17 by CD4 T cells stimulated with IL-15,… |
1 mg |
16314-1 |
More Info
|
Y320 |
An inhibitor of the release of IL-17 by CD4 T cells stimulated with IL-15,… |
10 mg |
16314-10 |
More Info
|
Y320 |
An inhibitor of the release of IL-17 by CD4 T cells stimulated with IL-15,… |
25 mg |
16314-25 |
More Info
|
Y320 |
An inhibitor of the release of IL-17 by CD4 T cells stimulated with IL-15,… |
5 mg |
16314-5 |
More Info
|
Y-33075 |
An inhibitor of ROCK2 (IC50 = 3.6 nM); selective for ROCK2 over PKC and Ca… |
1 mg |
35108-1 |
More Info
|
Y-33075 |
An inhibitor of ROCK2 (IC50 = 3.6 nM); selective for ROCK2 over PKC and Ca… |
10 mg |
35108-10 |
More Info
|
Y-33075 |
An inhibitor of ROCK2 (IC50 = 3.6 nM); selective for ROCK2 over PKC and Ca… |
5 mg |
35108-5 |
More Info
|
Yamogenin |
A steroidal sapogenin with diverse biological activities; inhibits T090131… |
1 mg |
36008-1 |
More Info
|
Yamogenin |
A steroidal sapogenin with diverse biological activities; inhibits T090131… |
10 mg |
36008-10 |
More Info
|
Yamogenin |
A steroidal sapogenin with diverse biological activities; inhibits T090131… |
25 mg |
36008-25 |
More Info
|
Yamogenin |
A steroidal sapogenin with diverse biological activities; inhibits T090131… |
5 mg |
36008-5 |
More Info
|
Yangonin |
A natural kavalactone that enhances the binding of bicuculline at the GABA… |
1 mg |
14351-1 |
More Info
|
Yangonin |
A natural kavalactone that enhances the binding of bicuculline at the GABA… |
10 mg |
14351-10 |
More Info
|
Yangonin |
A natural kavalactone that enhances the binding of bicuculline at the GABA… |
25 mg |
14351-25 |
More Info
|
Yangonin |
A natural kavalactone that enhances the binding of bicuculline at the GABA… |
5 mg |
14351-5 |
More Info
|
Yangonin |
An analytical reference standard categorized as a kavalactone; intended fo… |
1 mg |
33883-1 |
More Info
|
Yangonin |
An analytical reference standard categorized as a kavalactone; intended fo… |
5 mg |
33883-5 |
More Info
|
Yatein |
A lignan with diverse biological activities; inhibits CYP3A4 (IC50 = 1 &mi… |
1 mg |
29766-1 |
More Info
|
Yatein |
A lignan with diverse biological activities; inhibits CYP3A4 (IC50 = 1 &mi… |
500 µg |
29766-500 |
More Info
|
YC-1 |
YC-1 is an NO-independent activator of soluble guanylyl cyclase. It inhibi… |
1 mg |
81560-1 |
More Info
|
YC-1 |
YC-1 is an NO-independent activator of soluble guanylyl cyclase. It inhibi… |
10 mg |
81560-10 |
More Info
|
YC-1 |
YC-1 is an NO-independent activator of soluble guanylyl cyclase. It inhibi… |
5 mg |
81560-5 |
More Info
|
YC-1 |
YC-1 is an NO-independent activator of soluble guanylyl cyclase. It inhibi… |
50 mg |
81560-50 |
More Info
|
YCH1899 |
A PARP1 and PARP2 inhibitor (IC50s = 50s = 1-14.1 nM); inhibits the prolif… |
1 mg |
39737-1 |
More Info
|
YCH1899 |
A PARP1 and PARP2 inhibitor (IC50s = 50s = 1-14.1 nM); inhibits the prolif… |
10 mg |
39737-10 |
More Info
|
YCH1899 |
A PARP1 and PARP2 inhibitor (IC50s = 50s = 1-14.1 nM); inhibits the prolif… |
5 mg |
39737-5 |
More Info
|
YCT529 |
A RARα antagonist (IC50 = 6.8 nM); selective for RARα over RAR… |
1 mg |
39995-1 |
More Info
|
YCT529 |
A RARα antagonist (IC50 = 6.8 nM); selective for RARα over RAR… |
5 mg |
39995-5 |
More Info
|
YE 120 |
An agonist of GPR35 (EC50 = 32 nM in a DMR assay using HT-29 cells); induc… |
1 mg |
29720-1 |
More Info
|
YE 120 |
An agonist of GPR35 (EC50 = 32 nM in a DMR assay using HT-29 cells); induc… |
5 mg |
29720-5 |
More Info
|
YF-2 |
A HAT activator; inhibits proliferation of CCRF-CEM, Hs 578T, A549, U251,… |
1 mg |
31230-1 |
More Info
|
YF-2 |
A HAT activator; inhibits proliferation of CCRF-CEM, Hs 578T, A549, U251,… |
10 mg |
31230-10 |
More Info
|
YF-2 |
A HAT activator; inhibits proliferation of CCRF-CEM, Hs 578T, A549, U251,… |
25 mg |
31230-25 |
More Info
|
YF-2 |
A HAT activator; inhibits proliferation of CCRF-CEM, Hs 578T, A549, U251,… |
5 mg |
31230-5 |
More Info
|
YH 239-EE |
A prodrug form of YH 239; inhibits the growth of OCI-AML-3 cells and halts… |
10 mg |
27678-10 |
More Info
|
YH 239-EE |
A prodrug form of YH 239; inhibits the growth of OCI-AML-3 cells and halts… |
25 mg |
27678-25 |
More Info
|
YH 239-EE |
A prodrug form of YH 239; inhibits the growth of OCI-AML-3 cells and halts… |
5 mg |
27678-5 |
More Info
|
YH 239-EE |
A prodrug form of YH 239; inhibits the growth of OCI-AML-3 cells and halts… |
50 mg |
27678-50 |
More Info
|
Y-27632 (hydrochloride) |
A potent, ATP-competitive inhibitor of ROCKs including p160ROCK (Ki = 140… |
1 mg |
10005583-1 |
More Info
|
Y-27632 (hydrochloride) |
A potent, ATP-competitive inhibitor of ROCKs including p160ROCK (Ki = 140… |
10 mg |
10005583-10 |
More Info
|
Y-27632 (hydrochloride) |
A potent, ATP-competitive inhibitor of ROCKs including p160ROCK (Ki = 140… |
5 mg |
10005583-5 |
More Info
|
Y-27632 (hydrochloride) |
A potent, ATP-competitive inhibitor of ROCKs including p160ROCK (Ki = 140… |
50 mg |
10005583-50 |
More Info
|
Y-33075 (hydrochloride) |
An inhibitor of ROCK2 (IC50 = 3.6 nM); selective for ROCK2 over PKC and Ca… |
1 mg |
36216-1 |
More Info
|
Y-33075 (hydrochloride) |
An inhibitor of ROCK2 (IC50 = 3.6 nM); selective for ROCK2 over PKC and Ca… |
10 mg |
36216-10 |
More Info
|
Y-33075 (hydrochloride) |
An inhibitor of ROCK2 (IC50 = 3.6 nM); selective for ROCK2 over PKC and Ca… |
25 mg |
36216-25 |
More Info
|
Y-33075 (hydrochloride) |
An inhibitor of ROCK2 (IC50 = 3.6 nM); selective for ROCK2 over PKC and Ca… |
5 mg |
36216-5 |
More Info
|
YIL 781 (hydrochloride) |
An antagonist of GHS-R1a (Ki = 0.017 µM); selective for GHS-R1a over… |
1 mg |
29217-1 |
More Info
|
YIL 781 (hydrochloride) |
An antagonist of GHS-R1a (Ki = 0.017 µM); selective for GHS-R1a over… |
10 mg |
29217-10 |
More Info
|
YIL 781 (hydrochloride) |
An antagonist of GHS-R1a (Ki = 0.017 µM); selective for GHS-R1a over… |
25 mg |
29217-25 |
More Info
|
YIL 781 (hydrochloride) |
An antagonist of GHS-R1a (Ki = 0.017 µM); selective for GHS-R1a over… |
5 mg |
29217-5 |
More Info
|
YK-009 |
An ionizable cationic lipid (pKa = 6.512); administration of SARS-CoV-2 Om… |
1 mg |
38282-1 |
More Info
|
YK-009 |
An ionizable cationic lipid (pKa = 6.512); administration of SARS-CoV-2 Om… |
10 mg |
38282-10 |
More Info
|
YK-009 |
An ionizable cationic lipid (pKa = 6.512); administration of SARS-CoV-2 Om… |
5 mg |
38282-5 |
More Info
|
YK-11 |
A partial agonist of the androgen receptor; activates androgen receptor tr… |
10 mg |
9003137-10 |
More Info
|
YK-11 |
A partial agonist of the androgen receptor; activates androgen receptor tr… |
100 mg |
9003137-100 |
More Info
|
YK-11 |
A partial agonist of the androgen receptor; activates androgen receptor tr… |
50 mg |
9003137-50 |
More Info
|
YK-3-237 |
An inhibitor of tubulin polymerization and an activator of SIRT1; inhibits… |
1 mg |
21516-1 |
More Info
|
YK-3-237 |
An inhibitor of tubulin polymerization and an activator of SIRT1; inhibits… |
10 mg |
21516-10 |
More Info
|
YK-3-237 |
An inhibitor of tubulin polymerization and an activator of SIRT1; inhibits… |
25 mg |
21516-25 |
More Info
|
YK-3-237 |
An inhibitor of tubulin polymerization and an activator of SIRT1; inhibits… |
5 mg |
21516-5 |
More Info
|
YKL-05-099 |
An inhibitor of SIK2 (IC50 = 0.04 µM for the human enzyme); selectiv… |
10 mg |
36116-10 |
More Info
|
YKL-05-099 |
An inhibitor of SIK2 (IC50 = 0.04 µM for the human enzyme); selectiv… |
25 mg |
36116-25 |
More Info
|
YKL-05-099 |
An inhibitor of SIK2 (IC50 = 0.04 µM for the human enzyme); selectiv… |
5 mg |
36116-5 |
More Info
|
YKL-05-099 |
An inhibitor of SIK2 (IC50 = 0.04 µM for the human enzyme); selectiv… |
50 mg |
36116-50 |
More Info
|
YL-109 |
An anticancer agent; inhibits the proliferation of MCF-7 and MDA-MB-231 ce… |
10 mg |
30290-10 |
More Info
|
YL-109 |
An anticancer agent; inhibits the proliferation of MCF-7 and MDA-MB-231 ce… |
25 mg |
30290-25 |
More Info
|